Question to the Home Office:

To ask His Majesty's Government what harm reduction policies they are implementing in relation to illicit drug use.

The Drug Strategy sets out our commitment that the government and our public services will continue to work together and share responsibility for creating a safer, healthier and more productive society. It is backed by increased funding across the system, including nearly £900 million of additional investment over 2022-2025, of which the largest amount, £780 million, is dedicated additional funding for the treatment and recovery system.

Delivering a world-class treatment and recovery system is one of the three key strategic priorities in the Drug Strategy.

As part of this priority, the Government continues to support a range of evidence-based approaches to reduce the health-related harms of drug misuse, such as maintaining the availability of needle and syringe programmes to prevent blood borne infections, widening the availability of naloxone to prevent overdose deaths and the rollout of the opioid treatment, depot buprenorphine.